---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-056696"
form_type: "8-K"
ticker: "NUTX"
cik: "0001479681"
company_name: "Nutex Health Inc."
filed_at: "2026-08-13T20:01:31+00:00"
generated_at: "2026-08-13T20:03:25.764813+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Fifth Circuit vacates NSA ghost-rate and bonus-exclusion rules; Nutex Health to benefit from higher QPA

## Summary
- On Aug 11, 2026, en banc Fifth Circuit in Texas Medical Association v. HHS vacated July 2021 Rule allowing ghost rates and excluding bonus/incentive payments from QPA.
- Court ruled insurers must include bonus and incentive payments and cannot use non-negotiated placeholder rates; vacatur upheld with enforcement discretion for existing QPAs until new rules.
- Ruling cites ghost rates suppressed QPA and led IDR arbitration awards exceeding QPA in 85% of cases.
- Nutex, as a provider negotiating under NSA, expects higher Qualifying Payment Amounts in insurer contracts and IDR disputes.
- Departments directed to promulgate new rules consistent with NSA; interim use of existing QPAs permitted.

## SEC filing metadata
- accession: 0001628280-26-056696
- form_type: 8-K
- ticker: NUTX
- cik: 0001479681
- company_name: Nutex Health Inc.
- filed_at: 2026-08-13T20:01:31+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479681/000162828026056696/0001628280-26-056696-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479681/000162828026056696/nutx-20260811.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-056696
- JSON: https://secwatch.observer/filing/0001628280-26-056696.json
- Plain text: https://secwatch.observer/filing/0001628280-26-056696.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
